$0.2754-6.74%
2026-10-06 close · prelimLoading chart…
Today's signals · No active technical signal.
Signal details →TScan Therapeutics last closed at $0.2754 (-6.74%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 673 of 741 stocks in Healthcare.
About this company
TScan Therapeutics last closed at $0.2754 (-6.74%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 673/741
Valuation grade C+
Related stocks
- Bristol Myers SquibbCustomer
T세포 치료제 공동개발·제휴 가능성이 큰 주요 빅파마 고객
- NovartisCustomer
세포·유전자치료 분야의 대표적 대형 파트너 후보
- PfizerCustomer
면역항암·세포치료 관련 대형 제약사로 협업 상대가 될 수 있음
About TScan Therapeutics
- What technical signals does TScan Therapeutics (TCRX) have?
- TScan Therapeutics current technical signals: no active technical signal.
- Is TScan Therapeutics a cup-and-handle pattern?
- No. TScan Therapeutics has no valid Cup signal right now.
- What published figures are available for TScan Therapeutics?
- Market cap: $15.63M. Trailing 12 months PER: -0.3×. Latest quarter PBR: 0.56×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about TScan Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy